Leaflet CLINDAMYCIN-MIP 600mg film-coated tablets


Indicated for: bacterial infections

Route of administration: oral

Substance: clindamycin (lincosamide antibiotic)

ATC: J01FF01 (Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins | Lincosamides)

Clindamycin is an antibiotic used to treat a wide range of bacterial infections, including skin, bone, joint, and respiratory tract infections. It works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.

The medication is available in the form of capsules, injectable solutions, or topical gels, depending on the type and severity of the infection. It is important to follow your doctor's instructions and complete the full course of treatment to prevent the development of bacterial resistance.

Side effects may include nausea, diarrhea, abdominal pain, or skin rashes. In rare cases, clindamycin use may lead to pseudomembranous colitis, a serious condition requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of clindamycin.

General data about CLINDAMYCIN-MIP 600mg

  • Substance: clindamycin
  • Date of last drug list: 01-05-2026
  • Commercial code: W53634002
  • Concentration: 600mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 16
  • Product type: generic
  • Price: 46.46 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: CHEPHASAAR CHEM. - PHARM. FABRIK GMBH - GERMANIA
  • Holder: MIP PHARMA GMBH - GERMANIA
  • Number: 7191/2014/02
  • Shelf life: 3 years

Concentrations available for clindamycin

  • 100mg
  • 150mg
  • 150mg/ml
  • 300mg
  • 300mg/2ml
  • 600mg

Compensation lists for CLINDAMYCIN-MIP 600mg MIP Pharma

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

46.46 RON

21.76 RON

24.70 RON